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A targeted disruption of the RI isoform of protein
kinase A (PKA) was created by using homologous recom-
bination in embryonic stem cells. Unlike the other reg-
ulatory and catalytic subunits of PKA, RI is the only
isoform that is essential for early embryonic develop-
ment. RI homozygous mutant embryos fail to develop a
functional heart tube at E8.5 and are resorbed at ap-
proximately E10.5. Mutant embryos show significant
growth retardation and developmental delay compared
with wild type littermates from E7.5 to E10.5. The ante-
rior-posterior axis of RI mutants is well developed,
with a prominent head structure but a reduced trunk.
PKA activity measurements reveal an increased basal
PKA activity in these embryos. Brachyury mRNA expres-
sion in the primitive streak of RI mutants is signifi-
cantly reduced, consistent with later deficits in axial,
paraxial, and lateral plate mesodermal derivatives. This
defect in the production and migration of mesoderm can
be completely rescued by crossing RI mutants to mice
carrying a targeted disruption in the C catalytic sub-
unit, demonstrating that unregulated PKA activity
rather than a specific loss of RI is responsible for the
phenotype. Primary embryonic fibroblasts from RI mu-
tant embryos display an abnormal cytoskeleton and an
altered ability to migrate in cell culture. Our results
demonstrate that unregulated PKA activity negatively
affects growth factor-mediated mesoderm formation
during early mouse development.
The cAMP-dependent protein kinase (PKA)1 is a multisub-
strate serine/threonine protein kinase responsible for modulat-
ing a vast number of cell physiological processes ranging from
the maintenance of basal transcription of specific genes (1, 2) to
rapid reorganization of the cytoskeleton (3, 4). The mechanism
by which PKA modulates cellular physiology is by covalent
modification of polypeptide substrates via reversible enzymatic
transfer of a phosphate moiety to a consensus phosphorylation
motif in the target protein (5). The number and range of protein
substrates phosphorylated by PKA is as varied as the cell
physiological processes which it is known to regulate. These
substrates occur in all cellular compartments, including the
nucleus, cytoplasm, and plasma membrane (6).
The PKA holoenzyme is a heterotetramer composed of two
N-terminally dimerized regulatory (R) subunits combined with
two catalytic (C) subunits (5). PKA is unique in that the regu-
latory domain of the enzyme is encoded by separate genes
located on different chromosomes. PKA is also unique in that
the mechanism of activation involves simple subunit dissocia-
tion upon binding of cAMP to the regulatory subunits, thereby
liberating catalytically active C subunits that diffuse through-
out the cell, phosphorylating protein substrates containing ap-
propriate consensus phosphorylation motifs.
Four regulatory (RI, RII, RI, and RII) and two catalytic
(C and C) isoform genes have been described in the mouse
(7). Messenger RNA and protein for the  isoforms of PKA (RI,
RII, and C) are found ubiquitously in the mouse and are
expressed during early embryogenesis, whereas the  isoforms
(RI, RII, and C) have more tissue-specific patterns of ex-
pression. RI expression is restricted to neurons, whereas RII
expression is highest in brain and brown and white adipose
tissues (8, 9). Expression of C is highest in brain with lower
levels in all tissues (10). The pattern of expression of R and C
isoforms has been examined at day 14 of embryogenesis in the
mouse (11). However, a more detailed study of the expression
and function of PKA isoforms during early stages of mamma-
lian development is lacking.
The cAMP/PKA signaling system is likely to play an impor-
tant role in early development, and several lines of experimen-
tation have suggested important pathways that are modified
by PKA activity. A potential requirement for PKA activity in
the regulation of zygotic gene activation in the preimplantation
mouse embryo has been documented (12, 13). Studies of Dro-
sophila imaginal disks demonstrate that imaginal disk cells
lacking PKA activity behave as if they have received an exces-
sive sonic hedgehog signal, resulting in dramatic pattern re-
specifications (14–18). These observations led to the hypothesis
that PKA acts to antagonize sonic hedgehog signaling and thus
repress hedgehog-responsive genes such as decapentaplegic,
patched, and wingless. By using constitutively active and dom-
inant negative forms of PKA, two independent studies have
shown that PKA acts as a common negative regulator of sonic
hedgehog signaling in the zebrafish embryo (19–21). Apart
from the role of PKA as a general negative regulator of sonic
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hedgehog signaling, research to date has not uncovered any
other specific roles for PKA in vertebrate development. One
recent report (22) has implicated PKA in even earlier stages of
vertebrate embryogenesis. In this study it was demonstrated
that dissociated zebrafish blastula cells required PKA activity
for activin induction of the early mesoderm marker genes
goosecoid and no tail. However, only mild effects were observed
in vivo by injection of a dominant negative regulatory subunit
of PKA on goosecoid and no tail expression. Furthermore, when
Joore et al. (22) injected 2–4 cell stage zebrafish embryos with
a constitutively active form of the catalytic subunit of PKA, it
had no effect. This is in direct contrast to injections of a similar
construct into 2–4 cell stage zebrafish embryos made by Ham-
merschmidt and McMahon (20), who observed that blastula
stage zebrafish embryos were exquisitely sensitive to a consti-
tutively active form of the catalytic subunit of PKA, resulting in
failure of a large fraction of these embryos. Recent evidence in
our laboratory has confirmed the sensitivity of vertebrate em-
bryos to a constitutively active form of PKA catalytic subunit.2
In this study we present evidence that increased basal PKA
activity resulting from targeted disruption of the RI isoform of
PKA affects signaling in the primitive streak, causing profound
deficits in the production of all mesoderm derivatives including
the heart.
EXPERIMENTAL PROCEDURES
Mapping the RI Gene—The mouse RI genomic sequences were
isolated from a Charon 4A  phage library containing partial HaeIII/
AluI fragments of BALB/c mouse genomic DNA. The promoter sites for
the mouse RI gene were determined by primer extension and S1
nuclease mapping.
RIREC3 Targeting Vector—In order to make a targeted disruption
in the RI gene, a 5.0-kb genomic HindIII fragment was isolated from
a 129svJ mouse  phage library using plaque hybridization screening
with a 514-bp XhoI-EcoRI [32P]cDNA probe from RI. A genomic frag-
ment was isolated that contains a 5 3.2-kb intron, the 170-bp exon 3,
and 1.5-kb of 3 sequence including exons 4 and 5. This genomic frag-
ment was then subcloned into a pUC18 vector. The vector was linear-
ized at the XhoI site in exon 3 corresponding to amino acid 77 in the RI
coding sequence. A neomycin resistance cassette containing the SV40
promoter, the neomycin phosphotransferase cDNA, and poly(A) se-
quence was blunt end-ligated into the XhoI site. A thymidine kinase
cassette containing the HSVtk promoter, the thymidine kinase cDNA,
and poly(A) sequence was inserted 5 to the genomic sequence using
EcoRI and BamHI sites in the pUC18 polylinker. This replacement type
targeting vector was designated RIREC3 and was linearized at the
BamHI site before electroporation into ES cells.
Transfection of ES Cells and Generation of Germ Line Chimeras—
The generation of germ line-competent ES cells in our laboratory has
been described (23). REK2 or REK3 ES cells were electroporated with
25 g of BamHI-linearized RIREC3 per 107 cells using a ProgenitorTM
II PG200 electroporator (Hoefer Scientific Instruments) and subse-
quently grown under double selection in G418 (280 g/ml) and ganci-
clovir (2 M). DNA from ES cell clones was analyzed by Southern blot
using a 1-kb SacI/HindIII RI genomic probe located 3 to the targeting
construct. Positively targeted clones were expanded and injected into
C57BL/6 blastocysts that were subsequently implanted into BL6/
CBAF1 pseudopregnant females. The resulting male chimeras were
mated with C57BL/6 females, and agouti offspring were genotyped by
Southern blot analysis. Both REK2- and REK3-derived male chimeras
passed the mutation through the germ line resulting in heterozygous
agouti offspring. Heterozygous agouti mice were then interbred and
thus maintained on the mixed (129svJ  C57BL/6) background for all
subsequent analyses.
Generation of RI/C/ Animals for Interbreeding—Targeting of
the C gene and creation of C null mutant mice are the subject of a
separate study (24). In order to generate RI/C/ mice, RI het-
erozygous female mice were crossed to C heterozygous male mice,
which are both on the 129svJ-C57BL/6 mixed background. Genotyping
of offspring for RI was carried out using the Southern blot strategy
described above. Genotyping of offspring for C was carried out using a
Southern blot strategy in which a 315-bp HindIII/EcoRI probe located
outside the C targeting construct was hybridized to BamHI-digested
genomic tail DNA. The targeted C allele yields a 1.4-kb band, whereas
the wild type allele yields a 4.1-kb band.
PCR Analysis of Yolk Sac DNA—Individual yolk sacs were dissected
away from the embryos in M2 media (Sigma) and transferred to 1 SET
buffer (10 mM Tris, pH 7.4, 1 mM EDTA, 1% SDS) followed by overnight
digestion with 300 g/ml proteinase K in a 45 °C water bath. Yolk sac
DNA was then extracted twice with phenol/chloroform and precipitated.
DNA was resuspended in a total volume of 25 and 1 l of the resus-
pended yolk sac DNA was used for PCR analysis with TaqDNA polym-
erase (PEC) using the following oligos at 1 M final concentration: (A)
RI 5 exon 3, 5-GAGGAGGCAAGACAGAT-3; (B) RI 3 exon 3, 5-
CTTTCTAACGTAGGAGG-3; (C) Neo 5-oligo, 5-TCGCATGATTGAA-
CAAG-3; (D) Neo 3-oligo, 5-AAGCACGAGGAAGCGGT-3. Reaction
conditions for RI exon 3 oligos were 94 °C for 1 min, 45 °C for 1 min,
and 72 °C for 1.5 min for 35 cycles. Reaction conditions for the neomycin
oligos were 94 °C for 1 min, 50 °C for 1 min, and 72 °C for 1.5 min for 35
cycles. Reaction conditions were optimized using the PCR OptimizerTM
Kit (Invitrogen). In order to genotype embryos from RI//C/ 
RI//C/ intercrosses, yolk sac DNA was isolated as described
above, and the following two sets of C-specific primers were used to
genotype for C: (A) C 5 exon 6, 5-CTGACCTTTGAGTATCTGCAC-
3; (B) C 3 exon 7, 5-GTCCCACACAAGGTCCAAGTA-3; (C) Neo
5-oligo, 5-GTGGTTTGTCCAAACTCATCAATGT-3; (D) C 3 intron
7, 5-AGACTACTGCTCTATCACTGA-3. Reaction conditions for the C
exon 6 and 7 oligos were 94 °C for 30 s, 62 °C for 30 s, and 72 °C for 30 s
for 30 cycles. Reaction conditions for the Neo and C intron 7 oligos
were 94 °C for 30 s, 62 °C for 30 s, and 72 °C for 1 min for 30 cycles.
Western Analysis and Kinase Assays—For Western analysis only,
E8.5 embryos were isolated in M2 media, rinsed through several
changes of ice-cold PBS, and placed directly into 20 l of 1 Laemmli
sample buffer and boiled for 5 min. Lysates were loaded directly onto
10% SDS-PAGE gels and subsequently transferred to nitrocellulose
membranes. Blots were blocked overnight, probed with an affinity-
purified polyclonal antibody to RI, and visualized using the Amersham
Biosciences ECLTM system. Kinase assays were performed as described
previously (8). Briefly, E8.5 embryos were isolated in M2 media, rinsed
through several changes of ice-cold PBS, and subsequently homoge-
nized on ice in 150 l of lysis buffer (20 mM Tris, pH 7.5, 250 mM
sucrose, 0.1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 10 mM dithio-
threitol, 1 g/ml leupeptin, 3 g/ml aprotinin, 40 g/ml soybean trypsin
inhibitor, 0.5 mM 4-(2-aminoethyl)benzenesulfonyl fluoride) in a Dounce
homogenizer followed by sonication using a Branson Sonifier 250 (5
pulses: output 3, duty cycle 50%). Homogenates were then snap-frozen
and stored at 80 °C. Homogenates were thawed on wet ice and kinase
assays performed in triplicate in the presence and absence of 5 M
cAMP with Leu-Arg-Arg-Ala-Ser-Leu-Gly (Kemptide) as the substrate.
Assays were also performed in the presence of 40 g/ml protein kinase
inhibitor peptide-(5–24) to demonstrate that the kinase activity was
PKA-specific (25). Bradford assays (Bio-Rad) were performed to deter-
mine protein concentration, and kinase activity was normalized to
milligrams of protein.
HPLC Analysis—HPLC analysis of RI wild type and knockout E8.5
primary embryonic fibroblasts was performed as described (26). Briefly,
fibroblasts were grown on gelatin-coated 60-mm dishes in 10% FBS/
DMEM and incubated in a 5% CO2 incubator at 37 °C. Cells were lysed
in homogenization buffer and stored at 80 °C until the day of the
assay. The sample was diluted with homogenization buffer to a final
concentration of 1–2 mg/ml, loaded onto a DEAE/HPLC column, and
eluted using a linear salt gradient from 0 to 250 mM. Immediately
following the HPLC separation, fractions were collected and assayed for
kinase activity in the presence and absence of 5 M cAMP with Kemp-
tide as a substrate (8).
Histology—Embryos were isolated in M2 media and fixed in
Methacarnoys fixative (3:1.5:0.5 methanol/chloroform/glacial acetic
acid) at room temperature. After fixation, embryos were processed
through methanol (3 times for 15 min), methyl benzoate (1 times for 30
min), and xylenes (2 times for 15 min) and embedded in paraffin.
Paraffin blocks were sectioned at 8 m on a Reichert-Jung microtome,
and histological sections were stained with hematoxylin and eosin.
Sections were subsequently dehydrated through graded ethanols into
xylenes and coverslipped with PermountTM. Embryo sections were pho-
tographed on a Nikon Microphot-FXA microscope.
Whole Mount in Situ Analysis—Whole mount in situ analysis was
performed as described (27). The following cRNA probes were generated
as runoff transcripts using T3, T7, or SP6 RNA polymerase to generate
sense and antisense probes: (A) Brachyury (gift from Virginia Papaio-2 C. M. Niswender and G. S. McKnight, personal communication.
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annou) linearized with BamHI (antisense) or HindIII (sense) and (B)
Pax3 (gift from Peter Gruss) linearized with HindIII (antisense) or PstI
(sense). Whole mounts were photographed on a Nikon SMZ-U Dissect-
ing Scope.
Generation of Primary Embryonic Fibroblasts—The derivation of
primary embryonic fibroblasts has been described (28). Briefly, E8.5
mouse embryos were dissected out from the decidua, and all decidual
tissues were removed from the yolk sacs, including Reichardt’s mem-
brane. Yolk sacs were removed from each individual embryo and kept
for PCR analysis, and the amniotic membrane and allantois were re-
moved and discarded. RI mutant E8.5 embryos were easily identified
by their morphology. Mutant or wild type embryos were pooled and
placed in the tip of a 1-ml syringe in PBS and then triturated several
times with a 20-gauge needle into a 96-well plate containing 10%
FBS/DMEM and subsequently incubated in a 5% CO2 incubator at
37 °C. Primary embryonic fibroblasts were expanded from 96- to 24-well
to 60-mm dishes over several weeks. The genotype of RI mutant
primary embryonic fibroblasts was confirmed by yolk sac PCR and
Western analysis.
Cell Cycle Analysis Using Primary Embryonic Fibroblasts—Analysis
of cell cycle using DAPI staining has been described (29, 30). Briefly,
subconfluent RI mutant or wild type primary embryonic fibroblasts
growing in 10% FBS/DMEM in 5% CO2 at 37 °C were gently trypsinized
and subsequently washed twice through PBS and resuspended in 200
l of buffer containing 4,6-diamino-2-phenylindole (10 g/ml DAPI,
0.1% Nonidet P-40, 20 mM Tris, pH 7.5, 150 mM NaCl). The suspensions
were triturated with a 26-gauge needle and analyzed using a Coulter
ELITE cytometer with ultraviolet excitation and DAPI emission col-
lected at 450 nm. DNA content and cell cycle were analyzed using the
software program Multicycle.
In Vitro Migration Assay Using Primary Embryonic Fibroblasts—
Wild type and RI mutant primary embryonic fibroblasts were seeded
onto sterile glass coverslips in 12-well tissue culture dishes in 10%
FBS/DMEM and grown to confluency in a 5% CO2 incubator at 37 °C.
By using a p200 pipette tip, a wound was incised across the central area
of the coverslip, and a line perpendicular to the incision was made on
the bottom of the 12-well plate to mark the location for image collection.
Images were collected at 4-h intervals using a Leica inverted scope
interfaced with a Kodak 290 Digital camera and the Kodak Capture
DC290 software.
Confocal Imaging of Fibroblasts—For actin cytoskeletal visualiza-
tion, fibroblasts grown in 10% FBS/DMEM at 37 °C in a 5% CO2
incubator were seeded onto 1% gelatin-coated coverslips in 12-well
plates. At the time of staining, cells were fixed with 4% paraformalde-
hyde in PBS for 20 min, washed, delipidated with PBS containing 1%
Triton X-100 for 5 min, washed, blocked with 1% bovine serum albumin
in PBS for 20 min, and subsequently stained for 20 min with Texas Red
phalloidin (Amersham Biosciences). After staining, cells were washed
again and coverslipped in phosphate-buffered glycerol containing m-
phenylenediamine (Sigma) to counterstain the nuclei. Slides were im-
aged using a Bio-Rad MRC 600 confocal microscope using standard
excitation filters for Texas Red and fluorescein isothiocyanate labels.
For RI and C visualization, wild type and RI knockout fibroblasts
were seeded onto gelatin-coated coverslips in 12-well plates as above.
Cells were fixed in 4% paraformaldehyde at room temperature and then
blocked in a 2% biotin solution, a 2% avidin solution, and 10% normal
goat serum, Tris-buffered saline, 0.015% Triton X-100 at 4 °C over-
night. The following day cells were incubated in a 1:500 dilution of
either rabbit polyclonal anti-C or rabbit polyclonal anti-RI in 10%
normal goat serum, Tris-buffered saline, 0.015% Triton X-100 overnight
at 4 °C. The next day cells were washed, incubated in a 1:300 dilution
of biotinylated goat anti-rabbit antibody for 2 h, followed by a 1:300
dilution of avidin-fluorescein for 2 h. Cells were washed a final time and
coverslipped with vectashield containing 1.5 M propidium iodide to
visualize nuclei. Staining was visualized as mentioned above using the
Bio-Rad MRC600 confocal microscope using the Texas Red filter for
nuclei and the fluorescein isothiocyanate filter for C or RI.
RESULTS
Structure of the Mouse RI Gene—Mapping and sequencing
of  clones generated a map of the RI locus showing that the
gene contains 11 exons and spans about 18 kb in the mouse
genome. The position of intronic sequences within the coding
region corresponds to the genomic structure of the closely re-
lated mouse RI gene (31). A previous mapping of the human
RI gene showed only 10 exons (32), but a recent report dem-
onstrates 11 exons (33) indicating conservation between the
human and mouse RI genes. The promoter site for the mouse
RI gene was mapped by primer extension and S1 mapping
and revealed multiple start sites within a GC-rich 5-flanking
region with no recognizable TATA or CCAAT box homologies.
This promoter and first non-coding exon corresponds to pro-
moter 1a as characterized for the human RI gene. Other
promoter regions are used in humans (32) but all of these first
exons are non-coding and splice to the first coding exon, exon 2,
to give identical protein products. Fig. 1A shows a diagram of
the mouse RI gene and the overlapping  clones that were
analyzed, and Fig. 1B contains the sequence of the exons and
exon/intron boundaries as well as the sequence of the 1a pro-
moter region.
Targeting the RI Gene in Mice Results in Increased Basal
PKA Activity—In order to address the role of the RI isoform of
PKA in mouse development, we generated a targeted disrup-
tion of the gene. The targeting vector, RIREK3, contained a
neomycin resistance cassette inserted into exon 3 of a 5-kb
129svJ genomic fragment of the RI gene (Fig. 2A) and a
thymidine kinase cassette flanking the RI genomic coding
sequence. This targeting vector was electroporated into REK2
and REK3 ES cell lines (34), and Southern blot analysis iden-
tified clones from both REK2 and REK3 ES cells that had
homologously recombined the replacement vector sequence
into the RI gene (Fig. 2B). The targeting efficiency observed
for the construct over several electroporations was 1 in 30.
Targeted REK2 and REK3 ES cell lines were injected into
C57BL/6 blastocysts, and the resulting male chimeric offspring
were bred to C57BL/6 females. Chimeras generated from the
two independently derived targeted ES cell lines transmitted
the mutation through the germ line. The analysis of RI mu-
tant embryos in this study are derived from mice generated
from REK2- and REK3-targeted ES cell clones on the mixed
(129svJ  C57BL/6) background.
Mice carrying a heterozygous mutation in RI were viable,
fertile, and morphologically indistinguishable from wild type
littermates; however, interbreeding of RI heterozygotes to
generate RI homozygotes resulted only in wild type and het-
erozygous offspring in a 1:2 ratio. To determine the point at
which RI homozygous embryos were no longer viable, em-
bryos from heterozygous intercross matings were analyzed at
successive stages of development. Only resorption sites were
found upon initial inspection of embryos at E11.5; however, RI
mutant embryos were found in Mendelian ratios from E7.5 up
to E10.5 (Table I). PCR genotyping of yolk sac DNA using 5-
and 3-oligonucleotides to RI exon 3 confirmed that the mu-
tant embryos do indeed carry the disruption in exon 3 (Fig. 2C).
To confirm the absence of RI protein in homozygous mutant
embryos, mutant and wild type or heterozygote embryos were
homogenized directly in sample buffer and run on an SDS-
PAGE gel followed by probing with an affinity-purified poly-
clonal antibody to RI (Fig. 2D). Western blot analysis confirms
that RI protein is indeed absent in the phenotypically mutant
embryos.
To determine whether loss of the RI regulatory subunit
results in increased or decreased PKA activity, we performed
kinase assays on pooled E8.5 mutant and wild type or heterozy-
gote embryos (Fig. 3E). Although the total PKA activity is
decreased by 40%, basal PKA activity is increased substan-
tially in RI mutant embryos. The reduction in total PKA
activity in the absence of the RI subunit is consistent with
previous research in cell culture that has demonstrated that
the PKA catalytic subunit is unstable when not complexed to
regulatory subunits (35), suggesting that there is an increase in
free C subunit in RI mutant embryos that is also more rapidly
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degraded. Approximately 52% of the kinase activity in RI
mutant embryos is still cAMP-regulated, and Western blots
confirm the presence of RII in RI mutant embryos (Fig. 3E,
inset). Interestingly, up-regulation of RII is not observed in
RI mutants, which is consistent with observations made in
cell culture where PKA catalytic subunit was overexpressed
FIG. 1. Structure of the RI gene. A, genomic map of the RI gene locus showing the location of the 11 exons and the Charon 4A  phage clones
used for the analysis of the RI locus. B, sequence of the RI promoter and exons with positions of introns and intron/exon boundary sequences
shown. The region boxed in from nucleotides 171 to 223 contained multiple transcriptional start sites. Poly(A) addition signals are underlined in
the 3-untranslated region.
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(35). In fact, a decrease in RII levels is seen in the RI
knockout embryos that is also observed in primary embryonic
fibroblasts isolated from these embryos (Fig. 7B, inset).
Phenotype of RI Mutant Embryos—One of the most striking
features of RI mutant embryos when first observed was severe
growth retardation combined with developmental delay. Al-
though not morphologically evident in mid- and late-streak
stage embryos, the phenotype became clearly apparent from
the head-fold stage forward (Fig. 3B). Examination of over 30
RI mutant embryos at E9.5 revealed a very consistent mutant
phenotype. The anterior-posterior axis of RI mutant embryos
is clearly apparent, with a prominent head structure followed
by a greatly reduced trunk structure compared with wild type
E9.5 littermates (Fig. 3C and Fig. 4, A and B). The E9.5 RI
mutant embryo is equivalent in size to an E8.0 wild type
embryo (Fig. 3D). The most striking feature of the RI E9.5
mutant embryo when compared with an equivalently sized
E8.0 wild type embryo is the absence of a definitive heart tube
(Fig. 3, B and D). The cardiogenic plate is present (Fig. 3B), but
rather than being displaced more caudally by the formation of
FIG. 2. Targeted disruption of the RI gene. A, schematic representation of the targeting scheme. The top line shows a restriction map of
a 5-kb segment of the RI genomic coding sequence containing exons 3–5 that was subcloned into Bluescript KS. The middle line shows a
schematic representation of the targeting construct that has a neomycin resistance cassette subcloned into the XhoI site of exon 3. No genomic
coding sequence was removed in the targeting vector. A Southern blot of EcoRV-digested genomic DNA using the 3 SacI/HindIII genomic probe
indicated on the right of the targeting vector produces a 5.5-kb fragment for the wild type allele and a 7.5-kb band for the targeted allele. RI exon
3 oligos (black arrowheads) and neomycin oligos (white arrowheads) used for PCR genotyping of yolk sac DNA are indicated by arrowheads. A
thymidine kinase resistance cassette was subcloned into the multiple cloning site at the 5 end of the genomic sequence in the targeting vector to
select against random integrations. The bottom line shows the targeted locus in the RI gene that contains the neomycin cassette inserted into exon
3. B, EcoRV-digested genomic tail blots of agouti offspring obtained from breeding high percentage RI male chimeras to C57BL/6 females. The
blot was probed with the SacI/HindIII genomic probe indicated above. As expected, heterozygous agouti offspring show a 5.5- and a 7.5-kb band
indicating that the targeted RI allele has been transmitted through the germ line of RI male chimeras. C, PCR analysis using the yolk sac DNA
of embryos obtained from interbreeding RI heterozygous male and female offspring. The oligos used for PCR analysis in the top panel correspond
to the 5 and 3 end of RI exon 3 and should yield a 171-bp product if the wild type allele is present. RI homozygous mutant embryos lack this
171-bp product consistent with the disruption of exon 3 by insertion of the neomycin cassette into both alleles of the RI gene. In a separate reaction
shown in the bottom panel, 5- and 3-oligonucleotides internal to the neomycin resistance cassette were used which yield a 550-bp product if the
neomycin cassette is present and no product in wild type animals. D, 10 g of total protein from wild type and mutant homogenates used in the
kinase assays was run on an SDS-PAGE gel and transferred to nitrocellulose. The blot was subsequently probed with an affinity-purified polyclonal
antibody to RI. nt, nucleotide.
TABLE I
Distribution of genotypes in embryos and adult mice from RI
heterozygous matings
Age / / /
7.5 dpc 11 (33%) 19 (58%) 3 (9%)
8.5 dpc 7 (21%) 20 (59%) 7 (21%)
9.5 dpc 8 (27%) 13 (43%) 9 (30%)
10.5 dpca 5 (15%) 19 (58%) 9 (27%)
Postnatal 66 (33%) 124 (66%) 0 (0%)
a Histology on E10.5 mutants revealed extensive necrosis of tissues.
dpc, days post-coitum.
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the heart tube, it is tightly juxtaposed to the proencephalon.
The absence of a heart tube also results in a more radical angle
of entry of the foregut (Fig. 3D).
At E8.5, RI mutant embryos can be easily recognized by
their small size, flattened morphology (Fig. 3B), and ruffled
yolk sac membrane (not shown). Mutant embryos at this stage
resemble presomite head-fold stage wild type embryos and are
situated appropriately within the yolk sac and amniotic mem-
branes. At E7.5 the developmental delay is less apparent, al-
though E7.5 RI mutant embryos are smaller than wild type
littermates and have the characteristic flattened appearance
and ruffling of the yolk sac membrane.
Abnormal Cardiac Morphogenesis in RI Mutant Embry-
os—As mentioned in the previous section, although the cardi-
ogenic plate is present in E8.5 mutant embryos, no heart tube
is formed. Morphological and histological examination of the
cardiogenic plate reveals the presence of bilateral cardiocytes
located within the putative intraembryonic coelomic cavities
that have failed to fuse and thus form the pericardial cavity
(Fig. 4, C and D). Examination of one E11.5 litter containing
three RI mutant embryos revealed the presence of bilaterally
located cardiocytes within enlarged coelomic cavities that con-
tracted rhythmically at room temperature in M2 media at 36
FIG. 3. RI mutant embryos are severely growth-retarded and
have increased basal PKA activity. A, morphology of E7.5 wild type
and RI mutant embryos. Mutant embryos are smaller than wild type
littermates but have a well formed A-P axis, including head-folds, node,
and allantois. B, morphology of E8.5 wild type and RI mutant em-
bryos. Mutant embryos show severe growth retardation and develop-
mental delay resembling presomite head-fold stage embryos. The car-
diogenic plate is present but no heart tube has formed. C, morphology
of E9.5 wild type and RI mutant embryos. E9.5 mutant embryos are
severely growth-retarded, have failed to form a contractile heart tube,
and have not initiated the turning process. D, comparison of an E9.5
RI mutant embryo with wild type embryos from several stages of
development. Mutant embryos at E9.5 resemble E8.0 wild type em-
bryos. Although RI mutants are approximately the same size as E8.0
wild type embryos, mutants differ in that they have more somites, an
allantois that is thickened at the base, a more radical entry of the
foregut, and bilateral cardiocytes that have failed to fuse ventrally to
form the heart. Scale bars in A–D  500 M. The abbreviations used are
as follows: al, allantois; cp, cardiogenic plate; fg, foregut; hp, head
process; ht, heart; nd, node; tr, trunk; ys, yolk sac. E, basal and total
kinase activity in E8.5 wild type (WT) and RI mutant embryos. KO,
knockout. Mutant (n  2) and wild type (n  4) embryos were pooled
after removal of yolk sacs for PCR genotyping and homogenized in
kinase assay buffer. Kinase assays were performed in triplicate in the
presence and absence of cAMP using Kemptide as the substrate. Ho-
mogenates were also assayed in the presence of protein kinase inhibitor
to demonstrate that the measured kinase activity was PKA-specific.
Inset, Western analysis using polyclonal antibodies to RI or RII from
homogenates used for kinase assays.
FIG. 4. RI mutant embryos have deficiencies in cranial and
trunk mesenchyme. A, scanning electron microscopy of the head of an
E9.5 wild type embryo. Note the well developed forebrain, midbrain,
and hindbrain resulting from complete closure of the neural tube. The
first and second branchial arches are present and lie adjacent to the
pericardium. The otic vesicle has delaminated from the surface ecto-
derm, and the optic vesicle is visible. B, scanning electron microscopy of
the head of an E9.5 mutant embryo. Note the open neural tube in the
forebrain and midbrain region. Branchial arches are absent, and cra-
nial mesenchyme is severely deficient. The otic vesicle is present and
has delaminated from the surface ectoderm. C, E8.5 wild type embryo
showing ventral heart tube formation, including both endocardial and
myocardial elements suspended within the pericardium and attached
via the dorsal mesocardium. D, equivalent section through an E9.5
mutant embryo showing the absence of a ventral linear heart tube and
pericardium. Precardiac mesoderm is present on either side of the
midline of the pharynx. Note the persistence of the intraembryonic
coelomic cavities that have failed to fuse and form the pericardium. E,
whole mount in situ staining of an E9.5 RI mutant and an E9.5 wild
type embryo using a Pax 3 antisense riboprobe. Note the staining in the
10–12 tiny somites that lie adjacent to the neural tube. Somites in the
RI mutant are segmented but are greatly reduced in size and number
when compared with the E9.5 wild type littermate. F, ventral view of
E9.5 RI mutant compared with an E9.5 RI wild type littermate. Note
the absence of fusion of somites across the midline, indicating the
presence of notochord tissue. Scale bars in A–D  100 m; E and F 
500 m. The abbreviations used are as follows: am, amnion; cm, car-
diomyocytes; co, intraembryonic coelomic cavity; da, dorsal aorta; en,
endocardium; fg, foregut; hp, head process; mc, myocardium; ng, neural
groove; pcm, precardiac mesoderm; ph, pharynx; ysm, yolk sac
membrane.
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beats/min for several hours (not shown). Histological examina-
tion of these embryos revealed the presence of healthy bilateral
aggregations of cardiocytes, whereas the embryos themselves
were completely necrosed. These observations support the con-
clusion that at least some mesodermal cells arising from the
posterior epiblast of RI mutants have ingressed through the
primitive streak and migrated in the appropriate lateral and
anterior direction together with the definitive endoderm to
arrive at the heart field (36). Interestingly, the RI mutants
never initiate the turning process that would normally occur at
the 7–8 somite transition (37). The absence of turning is also
evident in the BMP 2 and GATA 4 knockouts that display
aberrant cardiac morphogenesis (38, 39). In the case of BMP 2,
a failure in the closure of the proamniotic canal results in the
formation of a single heart tube outside the amniotic mem-
brane (39). In the GATA 4 knockout, a failure of lateral to
ventral folding results in the formation of fully developed bi-
lateral heart tubes located dorsal to the aberrant foregut (38).
In the RI mutants, we hypothesize that the failure of the
bilateral cardiocytes to fuse ventrally arises from a deficiency
in the total number of mesodermal cells fated to become
cardiocytes.
Axial and Paraxial Mesoderm Is Formed and Expresses Ap-
propriate Markers but Is Greatly Reduced in Size—As men-
tioned previously, the anterior-posterior axis of RI mutant
embryos is well defined, including axial and paraxial mesoder-
mal derivatives. A morphological node is apparent in E7.5
mutant embryos (Fig. 3A), and the notochord is clearly present
in rostral sections of E9.5 mutant embryos (not shown). Al-
though paraxial mesoderm is formed and is segmented in RI
mutants, the somites are very small and irregularly shaped
(Fig. 4, E and F). The absence of fusion of somites along the
ventral midline suggests that notochord material must be pres-
ent along the rostro-caudal axis of RI mutants (Fig. 4F), as the
complete absence of notochord normally results in ventral fu-
sion of somites (40–42). Although the somites are small and
irregularly shaped, they do express the dermomyotomal
marker Pax 3, suggesting that dorsolateral differentiation of
the somites is progressing normally (Fig. 4E).
Reduced Primitive Streak and Abnormal Migration of Meso-
derm in RI Mutants—Due to the deficiencies observed in
mesodermal derivatives, we chose to look at earlier stages of
mesoderm formation in RI mutant embryos. Histological ex-
amination of E6.5 RI mutant embryos compared with E6.5
wild type littermates revealed aberrant migration of mesoder-
mal cells away from the primitive streak. Although wild type
late-streak stage embryos always exhibit very tightly ordered
columns of mesodermal cells that extend smoothly in a lateral
and anterior direction, the mutants display highly disorganized
movement away from the primitive streak (Fig. 5, A and B).
Quantitation of mesodermal cells that have exited the streak in
the embryonic portion of late-streak stage RI mutant embryos
indicates that mutants have approximately one-third the num-
ber of mesodermal cells that have exited the streak and moved
laterally and anteriorly (Fig. 5C). Reduction in primitive streak
mesoderm is also clearly visible 2 days later in the E8.5 RI
mutant embryo, where a significant reduction in brachyury
mRNA is observed (Fig. 5D). An accumulation of presumptive
mesoderm beneath the primitive streak that has failed to mi-
grate out laterally and anteriorly is observed in the E9.5 em-
bryo (not shown).
Loss of RI Alters Cell Morphology, Migration, and Localiza-
tion of C Subunit in Primary Embryonic Fibroblasts—To ad-
dress the hypothesis that increased PKA activity inhibits
growth factor signaling involved in the proliferation and mi-
gration of mesoderm from the primitive streak stage forward,
we isolated mesodermal primary embryonic fibroblasts from
E8.5 RI mutant and wild type embryos. Fibroblasts isolated
from these embryos were extremely unusual with respect to
overall morphology. Rather than showing the typical spindled
morphology of wild type fibroblasts, RI mutant fibroblasts are
flattened and show a box-shaped or rounded morphology. Ex-
amination of the actin cytoskeleton revealed that the RI mu-
tant fibroblasts have multiple actin organizing centers that
extend in all directions and an extensive subcortical actin cy-
toskeleton, whereas wild type fibroblasts display sparse paral-
lel actin fibers running from the leading to the lagging edge of
the cell (Fig. 6, A and B). To assess localization of C subunit,
confocal imaging was used on wild type and RI knockout E8.5
primary embryonic fibroblasts. C subunit is uniformly distrib-
uted throughout the cytoplasm of the wild type fibroblasts (Fig.
6C); however, in RI knockout fibroblasts, C subunit was pref-
erentially localized to the perinuclear space (Fig. 6D). Exami-
nation of RI localization revealed a uniform cytoplasmic dis-
tribution in wild type fibroblasts (Fig. 6E), similar to that
observed for C, whereas no staining was observed in RI
knockout fibroblasts (Fig. 6F). Cell cycle analysis of wild type
and RI mutant fibroblasts showed no difference in the per-
centage of cells in G0/G1, S, and G2/M (Fig. 7A). cAMP activa-
tion curves revealed high basal PKA activity in RI mutant
fibroblasts consistent with the unregulated PKA activity ob-
served in the RI knockout embryos (Fig. 7B). A small decrease
in total PKA activity was observed compared with wild type
fibroblasts combined with a decrease in RII levels in RI
knockout fibroblasts (Fig. 7B, inset). HPLC analysis of wild
type E8.5 primary embryonic fibroblasts reveals significant
quantities of type II holoenzyme along with type I holoenzyme
(Fig. 7C). Quantitation of the type II and type I holoenzyme
peaks indicates a type II to type I ratio of 3.5 to 1 in the wild
type cells and as expected no type I kinase in the mutants
(Fig. 7C).
Migration assays using an in vitro wound model demon-
strated that RI mutant fibroblasts completed wound healing
by 18 h, whereas wild type fibroblasts were significantly
slower at completing this process (Fig. 7D). This difference in
migration and “wound healing” was similar when fibronectin-
coated dishes were used in place of uncoated plastic. The sig-
nificantly faster closure of a scrape “wound” in cell culture by
RI mutant fibroblasts is superficially at odds with the ob-
served deficiency in mesoderm formation and migration out of
the primitive streak in RI knockout embryos. However, it is
likely that the complex environment at the primitive streak in
vivo, involving FGF-dependent receptor tyrosine kinase signal-
ing, E cadherin down-regulation, epithelial to mesenchymal
transition, and subsequent integrin-dependent migration of
nascent mesoderm over the endoderm is not adequately mod-
eled by this in vitro assay.
The Deficits in Mesodermal Derivatives Can Be Rescued by
Crossing RI Mutants to C Mutants—Based upon the hypoth-
esis that the defects observed in the mesoderm of RI mutants
is a result of increased basal PKA activity, we attempted to
rescue the RI mutant phenotype by crossing RI mutants to
C mutant mice that carry a null mutation in the C gene (24).
As C homozygous mutant mice are infertile and RI homozy-
gous mutant mice are embryonic lethals, we generated RI/C
double heterozygotes (RI//C/) by crossing RI heterozy-
gous females to C heterozygous males. The resulting RI//
C/ double heterozygous animals were viable and were in-
terbred to generate RI knockout animals on the C
heterozygous and C homozygous background. The first 32
offspring from a total of four litters yielded RI//C/ and
RI//C/ offspring at the expected Mendelian ratios of 1:8
Deficits in Mesoderm Formation in PKA Mutants27300
and 1:16. RI//C/ embryos were easily identified by their
morphology and display an intermediate phenotype clearly in-
dicative of partial rescue of the RI mutation (Fig. 8C). One of
the most dramatic features of RI//C/ is the presence of
a definitive heart tube located within a fluid-filled pericardial
cavity (Fig. 8C). Morphological and histological examination of
these embryos reveals a significant increase in all axial, parax-
ial, and lateral plate mesodermal derivatives, including in-
creased head mesenchyme, increased somite size and number,
and increased trunk length. Unlike the RI mutants, RI//
C/ embryos also seem to have initiated the turning process
(Fig. 8C). RI//C/ embryos showed an even greater de-
gree of rescue compared with the RI mutant phenotype (Fig.
8, B and D). RI//C/ shows dramatic increases in trunk
length, somite number and size, branchial arch and limb bud
development, and head mesenchyme. Unlike RI mutants,
RI//C/ also completes the turning process and has a
heart tube located within the pericardial cavity (Fig. 8, B and
D). Kinase activity measurements from the various genotypes
revealed a predictable decrease in total PKA activity but also a
graded decrease in basal PKA activity as C alleles are deleted
on the RI knockout background (Fig. 8E). Genotyping of new-
born pups from several RI//C/ interbreedings has failed
to yield viable RI knockout animals, suggesting that the lack
of RI protein on the C knockout background is still lethal.
Examination of RI//C/ embryos at midgestation (E10.5)
revealed an expanded fluid-filled pericardial cavity, suggesting
cardiovascular failure in the absence of RI at a later stage in
development.
DISCUSSION
We have utilized targeted disruption of PKA subunit genes
to determine the developmental and physiological roles of in-
dividual isoforms of the PKA family of genes in the mouse.
Disruption of the RII subunit that is expressed ubiquitously
at all stages of development did not lead to any developmental
deficits, and the animals were healthy and fertile (43). How-
ever, in this report we show that disruption of the other ubiq-
uitous R subunit, RI, results in a dramatic developmental
phenotype. This phenotype is characterized by mesodermal
insufficiency, and the early manifestations are caused by inap-
propriately regulated C subunit activity because we can par-
tially rescue the RI mutant embryos by breeding them onto a
C knockout genotype that reduces the total level of C subunit
in the mutants.
The observation that receptor-tyrosine kinases are critical
for mesoderm formation combined with the substantial litera-
ture on PKA-dependent inhibition of receptor tyrosine kinase
FIG. 5. Deficiencies in mesoderm formation begin at gastrulation. A, representative eosin-hematoxylin-stained 8-m section through a
wild type E6.5 late streak stage embryo. Note the thick and highly ordered columns of mesodermal cells that have exited the primitive streak and
moved laterally and anteriorly. Inset, outline of the embryo showing the approximate location of the section. B, representative eosin-hematoxylin-
stained 8-m section through an RI mutant late streak stage embryo. Note the reduced number of mesodermal cells that have exited the streak
and the highly disorganized manner in which the cells have exited the streak to move anteriorly. Inset, outline of the embryo showing the
approximate location of the section. C, quantitation of the number of mesodermal cells that have exited the streak in the embryonic portion of wild
type (n  2) and RI mutant (n  2) late-streak stage embryos. Data are the total number of mesodermal cells  S.D. that have exited the streak
from four representative 8-m sections for each embryo. Sections were at the same level for each embryo. D, whole mount in situ staining of an
E8.5 wild type and RI mutant embryo using a brachyury antisense riboprobe. Note the greatly reduced staining in the primitive streak region
as compared with the wild type embryo. Scale bars in A and B  50 m; D  500 m. The abbreviations used are as follows: ant, anterior; ect,
ectoderm; end, endoderm; mes, mesoderm; pos, posterior; ps, primitive streak.
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signaling led to the hypothesis that increased PKA activity in
the RI mutants might be antagonizing growth factor-depend-
ent signaling in the primitive streak. This possibility is con-
sistent with the greatly reduced brachyury whole mount in situ
staining in the primitive streak of RI mutants and the defi-
ciencies in anterior mesoderm-derived structures. The accumu-
lation of nascent mesoderm at the base of the primitive streak
also suggests deficits in integrin-dependent cell migration over
the endoderm which also depends upon growth factor receptor-
tyrosine kinases and extracellular matrix signals (44). Tar-
geted disruption in mice of several key proteins involved in
integrin-mediated signaling and migration, including fibronec-
tin and focal adhesion kinase (FAK), result in the failure of
embryos at gastrulation (45–47). FAK-deficient and fibronec-
tin-deficient embryos bear a striking resemblance to each other
and to RI mutant embryos, including growth retardation,
developmental delay, failure of cardiac morphogenesis, and
anterior mesoderm deficits. The similarities in the phenotypes
of FAK, fibronectin, and RI mutant embryos combined with
the literature describing PKA-dependent regulation of the ac-
tin cytoskeleton support the hypothesis that growth factor/
integrin signaling may be affected (3, 4). Activation of PKA
causes dephosphorylation of paxillin via increasing a tyrosine
phosphatase activity (48). More recent evidence demonstrates
that PKA can phosphorylate and activate Shp2, a tyrosine
phosphatase that localizes to focal adhesion complexes and
dephosphorylates both paxillin and FAK (49, 50). Related stud-
ies reveal that the p21-activated kinases are also critical for the
integration of growth factor and integrin-extracellular matrix
signals with the actin cytoskeleton (51, 52). Significantly, PKA
activity also negatively regulates p21-activated kinase and
thus interferes with its ability to mediate anchorage-dependent
growth factor responses (53). Isolation of primary embryonic
fibroblasts from E8.5 RI mutant embryos reveals a profound
disruption of the actin-based cytoskeleton. These fibroblasts
bear a striking resemblance to FAK-deficient and Shp2-defi-
cient primary embryonic fibroblasts, including a dramatic in-
crease in focal adhesions and condensed F-actin aggregation at
the cell periphery (47, 54). Expression of a dominant negative
Shp2 tyrosine phosphatase prevents paxillin and FAK dephos-
phorylation and results again in increased focal adhesions and
impaired migration (49), suggesting that successive cycles of
phosphorylation/dephosphorylation are required for directed
FIG. 6. Confocal imaging of the actin-based cytoskeleton, C,
and RI localization in E8.5 RI knockout and wild type pri-
mary embryonic fibroblasts. Confocal image of Texas Red phalloi-
din-stained wild type E8.5 primary embryonic fibroblasts (A) and RI
mutant E8.5 primary embryonic fibroblasts (B). Fibroblasts were
seeded onto glass coverslips in 12-well dishes, fixed, permeabilized,
incubated with Texas Red phalloidin, and subsequently washed and
coverslipped. The actin cytoskeleton (red) was visualized by confocal
microscopy with appropriate filters. Nuclei were counterstained with
m-phenylenediamine (green). C staining of wild type E8.5 primary
embryonic fibroblasts (C) and RI knockout E8.5 primary embryonic
fibroblasts (D) are shown. Cells were seeded onto glass coverslips in
12-well dishes, fixed, permeabilized, blocked, and incubated with a
rabbit polyclonal antibody to C followed by biotin anti-goat antibody
and avidin-fluorescein. C localization (green) and nuclei counter-
stained with propidium iodide (red) were visualized as above. RI
staining in wild type E8.5 primary embryonic fibroblasts (E) and RI
knockout E8.5 primary embryonic fibroblasts (F) are shown. Cells were
treated exactly as in the C staining, but a rabbit polyclonal antibody to
RI was used in lieu of the C antibody. Scale bars  100 m.
FIG. 7. Analysis of cell cycle parameters, kinase activity, ho-
loenzyme assembly, and cell migration in RI knockout (KO)
and wild type (WT) E8.5 primary embryonic fibroblasts. A, cell
cycle analysis of RI mutant and wild type E8.5 primary embryonic
fibroblasts. Fibroblasts grown in 60-mm dishes in 10% FBS/DMEM in
5% CO2 at 37 °C were washed, trypsinized, washed, and resuspended in
200 l of DAPI buffer. Fibroblasts were subsequently run through a
Coulter counter to measure the DAPI fluorescence over 20,000 cells.
DNA histograms were subsequently analyzed for cell cycle parameters
using the “multicycle” software package. B, cAMP activation curves
with RI wild type E8.5 primary embryonic fibroblasts and RI knock-
out E8.5 primary embryonic fibroblasts. Cells in 60-mm dishes were
washed and lysed in homogenization buffer, sonicated, and stored at
80 °C until the day of the assay. Samples were thawed and homoge-
nates assayed in triplicate with various concentrations of cAMP using
the standard kinase assay described under “Experimental Procedures.”
cAMP activation curves were performed three times with similar re-
sults. Inset, Western analysis from homogenates of wild type and RI
knockout primary embryonic fibroblasts using polyclonal antibodies to
RI or RII. C, kinase assays on fractions obtained by HPLC DEAE
ion-exchange fractionation of homogenates from E8.5 wild type and RI
knockout primary embryonic fibroblasts. Cells were grown in 60-mm
dishes, washed, lysed, sonicated, and stored at 80 °C until the day of
the assay. On the day of the assay, 1–2 mg of protein homogenate was
loaded on a 2-ml DEAE ion-exchange column and separated by HPLC
into 1-ml fractions over a 0–250 mM salt gradient. Fractions were
assayed the same day by kinase assay as described under “Experimen-
tal Procedures.” D, in vitro wound assay monitoring the migration of
RI mutant and wild type fibroblasts. Fibroblasts were seeded onto
glass coverslips in 12-well dishes and allowed to grow to confluency. An
incision was made across the center of the coverslip using a p200 pipette
tip; the media were replaced, and migration of fibroblasts back into the
artificial wound was monitored using an Leica inverted scope interfaced
with a Kodak DC290 digital camera and accompanying software. Mag-
nification  100.
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cell migration and that PKA may also be involved in this
process.
We hypothesize that the defects observed in mesodermal
derivatives result from antagonism of growth factor-mediated
production and migration of mesoderm out of the primitive
streak. The fact that we can incrementally rescue all the me-
sodermal derivatives of the primitive streak by reducing the
total amount of C subunit supports the hypothesis that exces-
sive catalytic subunit activity is antagonizing growth factor
signaling in the primitive streak. These observations support a
model in which PKA plays a role as a general negative regula-
tor of growth factor signaling in the primitive streak, not unlike
its role as a general negative regulator of sonic hedgehog sig-
naling in vertebrates (19, 20). Whether the cAMP/PKA path-
way is normally involved in regulating receptor tyrosine kinase
signaling in the primitive streak via endogenous G-protein-
coupled receptors remains to be demonstrated.
Is there a specific role for RI in mouse embryo development?
C knockout animals are developmentally normal, and it is
only postnatally that they manifest growth retardation and a
failure to thrive (24). The observation that RI knockout em-
bryos on the C knockout background suffer cardiovascular
failure at midgestation suggests a specific and novel role for
RI in cardiac development. It is unlikely that the midgesta-
tion cardiovascular failure of RI knockouts on the C knock-
out background is due to an overall decrease in C subunit
activity, as C knockouts show a significant decrease in C
subunit activity in the heart and survive to adulthood. Further-
more, mice with only one remaining C subunit allele (C or C)
also survive to birth and have normal cardiac development
(55). There is evidence for specific localization of RI containing
holoenzyme by interaction between scaffolding proteins and
the N terminus of RI. For example, RI localizes to the neu-
romuscular junction in skeletal muscle and the fibrous sheath
in mammalian spermatozoa (56, 57).
A unique role for the RI regulatory subunit has been dem-
onstrated recently in the human disease known as Carney
complex (33, 58). One of the disease loci in humans has been
mapped to the RI gene located on human chromosome 17q24
and consists of heterozygous mutations in the RI coding se-
quence or splice junctions that prevent RI protein expression
and also appear to lead to mRNA degradation. Patients suffer-
ing from loss of heterozygosity due to somatic mutations in the
remaining RI allele present with a multiple neoplasia syn-
drome characterized by spotty pigmentation of the skin, endo-
crine tumors, melanotic schwannomas, and cardiac myxomas.
The mechanism by which the loss of heterozygosity leads to
these clinical manifestations is unclear. One possible mecha-
nism is increased basal PKA activity due to loss of regulation;
however, direct analysis of adrenal and ovarian tumors did not
show an increase in basal but instead revealed an increase in
total PKA activity (58). The RI heterozygous mice should
serve as an animal model and provide an opportunity to explore
the underlying mechanisms leading to the pathology of Carney
complex.
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